Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.6%

1 terminated out of 62 trials

Success Rate

96.4%

+9.9% vs benchmark

Late-Stage Pipeline

11%

7 trials in Phase 3/4

Results Transparency

15%

4 of 27 completed with results

Key Signals

4 with results96% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (16)
P 2 (3)
P 3 (5)
P 4 (2)

Trial Status

Completed27
Unknown16
Recruiting10
Active Not Recruiting3
Withdrawn3
Not Yet Recruiting2

Trial Success Rate

96.4%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT07312227Active Not Recruiting

A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in Bolivia

NCT01648855Completed

Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn

NCT07462182Not ApplicableNot Yet RecruitingPrimary

Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

NCT03662178Recruiting

Investigating the Structured Use of Ultrasound Scanning for Fetal Growth

NCT01729468Phase 4Completed

Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers

NCT02297724RecruitingPrimary

MRI Assessment of Placental Health

NCT02238301Not ApplicableCompletedPrimary

Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant Women

NCT04356326Phase 3Recruiting

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

NCT06226051Recruiting

Growing Little PEAPODS Study

NCT06115122Recruiting

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

NCT06988436CompletedPrimary

FETAL PULMONARY VEIN AND UMBILICAL ARTERY PULSATILITY INDICES AS PREDICTORS OF FETAL GROWTH RESTRICTION IN DIABETIC AND HYPERTENSIVE PREGNANT WOMEN

NCT02583763Active Not Recruiting

Cardiac Displacement From Third Trimester to Early Childhood

NCT04766866Not ApplicableRecruiting

sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.

NCT05253781Phase 3CompletedPrimary

Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)

NCT02523222Phase 2Completed

Dextrose Gel Does Not Prevent Neonatal Hypoglycemia

NCT05500989Recruiting

PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis

NCT06074601Active Not Recruiting

MIRACLE of LIFE Study

NCT04506970CompletedPrimary

Predicting Placental Pathologies by Ultrasound Imaging

NCT06534307RecruitingPrimary

Long-term Follow-up of Children Born in the PETN Studies

NCT03324139Phase 3CompletedPrimary

Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.

Scroll to load more

Research Network

Activity Timeline